Skip to main content

FOR US HEALTHCARE PROFESSIONALS ONLY

TYVASO and TYVASO DPI are approved for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise.

Cost assistance

ASSIST can help you determine if you qualify for United Therapeutics’ patient assistance programs.
Call ASSIST at 1-877-864-8437.

Co-Pay Assistance Program*

With the TYVASO Co-Pay Assistance Program, most eligible patients pay as little as a $5 co-pay for each prescription of TYVASO or TYVASO DPI.

Enroll today

Learn how to enroll at www.UTcopay.com or call ASSIST at 1-877-864-8437.

Get full program details and Terms and Conditions.

*Eligibility requirements for this Program are:

  • You must be 18 years or older to use this Program
  • Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible
  • The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDAapproved indication
  • Eligible patients must be a resident of the United States or Puerto Rico. The Program is subject to additional state law restrictions. Patients residing in select states may not be eligible for the Program

NOW APPROVED—TYVASO DPI FITS IN THE PALM OF YOUR HAND

Ask your healthcare provider about the
Dry Powder Inhaler (DPI) option now approved for TYVASO®.

bubbles pattern
hand holding dpi devicebubbles pattern

See how simple TYVASO DPI is to use.

bubbles pattern